Wolverine Asset Management LLC Increases Position in BlackRock Health Sciences Term Trust $BMEZ

Wolverine Asset Management LLC lifted its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 5,782.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 224,518 shares of the company’s stock after buying an additional 220,701 shares during the quarter. Wolverine Asset Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $3,238,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Baird Financial Group Inc. bought a new position in BlackRock Health Sciences Term Trust in the 1st quarter valued at $189,000. Geneos Wealth Management Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust during the first quarter valued at $40,000. SeaCrest Wealth Management LLC grew its holdings in shares of BlackRock Health Sciences Term Trust by 9.1% in the second quarter. SeaCrest Wealth Management LLC now owns 26,800 shares of the company’s stock worth $382,000 after purchasing an additional 2,245 shares during the last quarter. Chapin Davis Inc. increased its stake in BlackRock Health Sciences Term Trust by 31.4% in the 2nd quarter. Chapin Davis Inc. now owns 26,756 shares of the company’s stock worth $382,000 after buying an additional 6,400 shares during the period. Finally, Maridea Wealth Management LLC increased its stake in BlackRock Health Sciences Term Trust by 4.5% in the 2nd quarter. Maridea Wealth Management LLC now owns 43,277 shares of the company’s stock worth $617,000 after buying an additional 1,874 shares during the period.

BlackRock Health Sciences Term Trust Price Performance

BlackRock Health Sciences Term Trust stock opened at $15.40 on Friday. The firm has a 50-day moving average of $15.17 and a two-hundred day moving average of $14.68. BlackRock Health Sciences Term Trust has a 1 year low of $12.58 and a 1 year high of $16.75.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 8.6%.

Insider Activity

In other news, Director Robert W. Fairbairn sold 10,294 shares of the firm’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $14.98, for a total transaction of $154,204.12. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.